Marie Angèle Cucci, Margherita Grattarola, Chiara Monge, Antonella Roetto, Giuseppina Barrera, Emilia Caputo, . . . Stefania Pizzimenti. (2023). Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma. MDPI AG.
Chicago Style (17th ed.) CitationMarie Angèle Cucci, Margherita Grattarola, Chiara Monge, Antonella Roetto, Giuseppina Barrera, Emilia Caputo, Chiara Dianzani, and Stefania Pizzimenti. Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma. MDPI AG, 2023.
MLA (9th ed.) CitationMarie Angèle Cucci, et al. Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.